TUCSON, Ariz., June 29, 2015 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, was added to the Russell Microcap® Index following the conclusion of the Russell indexes annual reconstitution on June 26, 2015.
Membership in the Russell Microcap Index, which generally remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $5.7 trillion in assets are benchmarked to the Russell U.S. Indexes. Russell Indexes are part of FTSE Russell, a leading global index provider.
About HTG:
Headquartered in Tucson, Arizona, HTG Molecular Diagnostics' mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of RNA assays that leverage HTG's proprietary nuclease protection chemistry. HTG Edge system capabilities have been expanded to fully automate sample and targeted library preparation for next-generation sequencing.
Safe Harbor Statement:
Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with the Russell Microcap® Index and other Russell Indexes, and the capabilities of HTG's technology. These forward-looking statements are based upon HTG's current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results or events, and the timing thereof, could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, including, without limitation, risks involved in the development and commercialization of products. These and other factors are described in greater detail in HTG's filings with the Securities and Exchange Commission, including without limitation HTG's Form 10-Q for the quarter ended March 31, 2015. All forward-looking statements contained in this press release speak only as of the date on which they were made, and HTG undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.